We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Nobelpharma

News List

Nobelpharma Signs License Agreement to Use ProBioGen’s Vaccine Production Platform contractpharma
August 13, 2021
The cell-based system for vaccine production offers a cost-effective, efficient and flexible alternative to traditional vaccine production.
Nobelpharma Signs a License Agreement for ProBioGen’s Vaccine Manufacturing Platform AGE1.CR.pIX® b3cnewswire
August 13, 2021
ProBioGen is pleased to announce that Nobelpharma has signed a license agreement for the use of the AGE1.CR.pIXvaccine production platform to develop their lead vaccine.
ProBioGen, Nobelpharma Enter Mfg. Agreement for Vax Project contractpharma
March 25, 2021
ProBioGen AG signed a service agreement for Nobelpharma’s vaccine project leveraging ProBioGen’s vaccine development platform consisting of its AGE1.CR.pIX suspension cell line and its high performance cell culture medium, for the propagation of ...